BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 25931483)

  • 1. What is new about Rio?
    Souza R; Kawut SM
    Eur Respir J; 2015 May; 45(5):1211-3. PubMed ID: 25931483
    [No Abstract]   [Full Text] [Related]  

  • 2. Changing perceptions in pulmonary hypertension.
    Gerges C; Lang IM
    Lancet Respir Med; 2014 Jan; 2(1):21-3. PubMed ID: 24461891
    [No Abstract]   [Full Text] [Related]  

  • 3. [Riociguat - a stimulator of soluble guanylate cyclase: a new mode of action helps patients with pulmonary hypertension].
    Kreutzkamp B
    Med Monatsschr Pharm; 2013 Dec; 36(12):442-7. PubMed ID: 24450268
    [No Abstract]   [Full Text] [Related]  

  • 4. The safety and effectiveness of riociguat to treat chronic thromboembolic pulmonary hypertension.
    DeSouza SA; Preston IR
    Expert Rev Cardiovasc Ther; 2015 May; 13(5):467-76. PubMed ID: 25797801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Riociguat recommended by CHMP for approval in the EU for use in two forms of pulmonary hypertension.
    Dowdall M
    Future Cardiol; 2014 Mar; 10(2):163. PubMed ID: 24883440
    [No Abstract]   [Full Text] [Related]  

  • 6. Unusual Bleeding Due to Riociguat Use in a Patient With Chronic Thromboembolic Pulmonary Hypertension.
    Sonmez A; Sunbul M; Yildizeli B; Mutlu B
    Am J Ther; 2016; 23(5):e1253-4. PubMed ID: 26270800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into pulmonary hypertension.
    Furlow B
    Lancet Respir Med; 2013 Sep; 1(7):508. PubMed ID: 24461605
    [No Abstract]   [Full Text] [Related]  

  • 8. Riociguat (Adempas). Chronic thromboembolic pulmonary hypertension with markedly restricted physical activity.
    Prescrire Int; 2015 Nov; 24(165):265-6. PubMed ID: 26688897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The PATENT-1 and CHEST-1 studies].
    Casu G; Scelsi L; Morsolini M; D'Armini AM
    G Ital Cardiol (Rome); 2015 Feb; 16(2):59-64. PubMed ID: 25805087
    [No Abstract]   [Full Text] [Related]  

  • 10. [Targeted therapy of pulmonary arterial hypertension (PAH)].
    Klose H; Opitz C; Bremer H; Ewert R; Bonderman D; Rosenkranz S; Seeger W; Schmeißer A; Harbaum L; Buerke M; Ghofrani HA; Borst MM; Leuchte HH; Lange TJ; Behr J; Ulrich S; Lang I; Olschewski H; Gall H; Kabitz HJ; Kleber FX; Held M; Hoeper MM; Grünig E
    Dtsch Med Wochenschr; 2014 Dec; 139 Suppl 4():S142-50. PubMed ID: 25489684
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pulmonary hypertension].
    Kovacs G; Olschewski H
    Dtsch Med Wochenschr; 2012 Oct; 137(40):2026-8. PubMed ID: 23023615
    [No Abstract]   [Full Text] [Related]  

  • 12. Riociguat for pulmonary hypertension.
    Pitonzo D; Archambault ME
    JAAPA; 2016 Jun; 29(6):60-2. PubMed ID: 27228047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recruitment of pulmonary hypertension patients for PATENT trial with Riociguat [corrected] completed Sub-Saharan pulmonary hypertension study launched.
    Aalbers J
    Cardiovasc J Afr; 2012 Mar; 23(2):120. PubMed ID: 22447482
    [No Abstract]   [Full Text] [Related]  

  • 14. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2).
    Simonneau G; D'Armini AM; Ghofrani HA; Grimminger F; Hoeper MM; Jansa P; Kim NH; Wang C; Wilkins MR; Fritsch A; Davie N; Colorado P; Mayer E
    Eur Respir J; 2015 May; 45(5):1293-302. PubMed ID: 25395036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Riociguat for pulmonary hypertension.
    Cannon JE; Pepke-Zaba J
    Expert Rev Clin Pharmacol; 2014 May; 7(3):259-70. PubMed ID: 24580082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is distal chronic thromboembolic pulmonary hypertension treatable with PAH targeted drugs?
    Cannon JE; Pepke-Zaba J
    Semin Respir Crit Care Med; 2013 Oct; 34(5):620-6. PubMed ID: 24037629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-in-class guanylate cyclase stimulator approved for PAH.
    Guha M
    Nat Biotechnol; 2013 Dec; 31(12):1064. PubMed ID: 24316627
    [No Abstract]   [Full Text] [Related]  

  • 18. Riociguat: a novel therapeutic option for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
    Mielniczuk LM; Swiston JR; Mehta S
    Can J Cardiol; 2014 Oct; 30(10):1233-40. PubMed ID: 25154043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Riociguat (Adempas) for pulmonary hypertension.
    Med Lett Drugs Ther; 2014 Mar; 56(1437):17-9. PubMed ID: 24589497
    [No Abstract]   [Full Text] [Related]  

  • 20. Riociguat for pulmonary hypertension.
    Post MC
    N Engl J Med; 2013 Dec; 369(23):2267. PubMed ID: 24304060
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.